Search

Your search keyword '"Olman, Mitchell A."' showing total 14 results
Start Over Author "Olman, Mitchell A." Topic 3. good health
14 results on '"Olman, Mitchell A."'

1. Additional file 3 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort

Author

Todd, Jamie L., Vinisko, Richard, Liu, Yi, Neely, Megan L., Overton, Robert, Flaherty, Kevin R., Noth, Imre, L. Kristin Newby, Lasky, Joseph A., Olman, Mitchell A., Hesslinger, Christian, Leonard, Thomas B., Palmer, Scott M., and Belperio, John A.

Subjects
respiratory system, 3. Good health
Abstract

Additional file 3: Median (first quartile, third quartile) concentration for each MMP/TIMP stratified by tertile of FVC % predicted, DLCO % predicted, and CPI.

2. Additional file 5 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort

Author

Todd, Jamie L., Vinisko, Richard, Liu, Yi, Neely, Megan L., Overton, Robert, Flaherty, Kevin R., Noth, Imre, L. Kristin Newby, Lasky, Joseph A., Olman, Mitchell A., Hesslinger, Christian, Leonard, Thomas B., Palmer, Scott M., and Belperio, John A.

Subjects
behavior and behavior mechanisms, respiratory tract diseases, 3. Good health
Abstract

Additional file 5: Mean (standard deviation) log10 MMP and TIMP concentrations in the IPF and control populations as stratified by smoking status at enrollment (current/past smoker vs. never smoker).

3. Additional file 4 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort

Author

Todd, Jamie L., Vinisko, Richard, Liu, Yi, Neely, Megan L., Overton, Robert, Flaherty, Kevin R., Noth, Imre, L. Kristin Newby, Lasky, Joseph A., Olman, Mitchell A., Hesslinger, Christian, Leonard, Thomas B., Palmer, Scott M., and Belperio, John A.

Subjects
macromolecular substances, respiratory system, respiratory tract diseases, 3. Good health
Abstract

Additional file 4: Association of MMPs and TIMPs with measures of IPF severity, adjusted for anti-fibrotic treatment.

4. Additional file 6 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort

Author

Todd, Jamie L., Vinisko, Richard, Liu, Yi, Neely, Megan L., Overton, Robert, Flaherty, Kevin R., Noth, Imre, L. Kristin Newby, Lasky, Joseph A., Olman, Mitchell A., Hesslinger, Christian, Leonard, Thomas B., Palmer, Scott M., and Belperio, John A.

Subjects
respiratory system, respiratory tract diseases, 3. Good health
Abstract

Additional file 6: Mean (standard deviation) log10 MMP and TIMP concentrations in patients with IPF with or without clinically significant emphysema on CT scan as assessed by the enrolling physician.

5. Additional file 7 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort

Author

Todd, Jamie L., Vinisko, Richard, Liu, Yi, Neely, Megan L., Overton, Robert, Flaherty, Kevin R., Noth, Imre, L. Kristin Newby, Lasky, Joseph A., Olman, Mitchell A., Hesslinger, Christian, Leonard, Thomas B., Palmer, Scott M., and Belperio, John A.

Subjects
respiratory system, circulatory and respiratory physiology, respiratory tract diseases, 3. Good health
Abstract

Additional file 7: Model performance in the training (cross-validation) set for baseline FVC % predicted, DLCO % predicted and CPI.

6. Additional file 8 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort

Author

Todd, Jamie L., Vinisko, Richard, Liu, Yi, Neely, Megan L., Overton, Robert, Flaherty, Kevin R., Noth, Imre, L. Kristin Newby, Lasky, Joseph A., Olman, Mitchell A., Hesslinger, Christian, Leonard, Thomas B., Palmer, Scott M., and Belperio, John A.

Subjects
respiratory system, circulatory and respiratory physiology, respiratory tract diseases, 3. Good health
Abstract

Additional file 8: Model performance in the test set for baseline FVC % predicted, DLco % predicted and CPI.

7. Additional file 3 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort

Author

Todd, Jamie L., Vinisko, Richard, Liu, Yi, Neely, Megan L., Overton, Robert, Flaherty, Kevin R., Noth, Imre, L. Kristin Newby, Lasky, Joseph A., Olman, Mitchell A., Hesslinger, Christian, Leonard, Thomas B., Palmer, Scott M., and Belperio, John A.

Subjects
respiratory system, 3. Good health
Abstract

Additional file 3: Median (first quartile, third quartile) concentration for each MMP/TIMP stratified by tertile of FVC % predicted, DLCO % predicted, and CPI.

8. Additional file 6 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort

Author

Todd, Jamie L., Vinisko, Richard, Liu, Yi, Neely, Megan L., Overton, Robert, Flaherty, Kevin R., Noth, Imre, L. Kristin Newby, Lasky, Joseph A., Olman, Mitchell A., Hesslinger, Christian, Leonard, Thomas B., Palmer, Scott M., and Belperio, John A.

Subjects
respiratory system, respiratory tract diseases, 3. Good health
Abstract

Additional file 6: Mean (standard deviation) log10 MMP and TIMP concentrations in patients with IPF with or without clinically significant emphysema on CT scan as assessed by the enrolling physician.

9. Additional file 7 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort

Author

Todd, Jamie L., Vinisko, Richard, Liu, Yi, Neely, Megan L., Overton, Robert, Flaherty, Kevin R., Noth, Imre, L. Kristin Newby, Lasky, Joseph A., Olman, Mitchell A., Hesslinger, Christian, Leonard, Thomas B., Palmer, Scott M., and Belperio, John A.

Subjects
respiratory system, circulatory and respiratory physiology, respiratory tract diseases, 3. Good health
Abstract

Additional file 7: Model performance in the training (cross-validation) set for baseline FVC % predicted, DLCO % predicted and CPI.

10. Additional file 1 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort

Author

Todd, Jamie L., Vinisko, Richard, Liu, Yi, Neely, Megan L., Overton, Robert, Flaherty, Kevin R., Noth, Imre, L. Kristin Newby, Lasky, Joseph A., Olman, Mitchell A., Hesslinger, Christian, Leonard, Thomas B., Palmer, Scott M., and Belperio, John A.

Subjects
3. Good health
Abstract

Additional file 1: Tertile cutpoints for disease severity metrics.

11. Additional file 2 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort

Author

Todd, Jamie L., Vinisko, Richard, Liu, Yi, Neely, Megan L., Overton, Robert, Flaherty, Kevin R., Noth, Imre, L. Kristin Newby, Lasky, Joseph A., Olman, Mitchell A., Hesslinger, Christian, Leonard, Thomas B., Palmer, Scott M., and Belperio, John A.

Subjects
respiratory system, respiratory tract diseases, 3. Good health
Abstract

Additional file 2: MMP and TIMP concentrations (pg/mL) in patients with IPF versus the control population.

12. Additional file 1 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort

Author

Todd, Jamie L., Vinisko, Richard, Liu, Yi, Neely, Megan L., Overton, Robert, Flaherty, Kevin R., Noth, Imre, L. Kristin Newby, Lasky, Joseph A., Olman, Mitchell A., Hesslinger, Christian, Leonard, Thomas B., Palmer, Scott M., and Belperio, John A.

Subjects
3. Good health
Abstract

Additional file 1: Tertile cutpoints for disease severity metrics.

13. Additional file 4 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort

Author

Todd, Jamie L., Vinisko, Richard, Liu, Yi, Neely, Megan L., Overton, Robert, Flaherty, Kevin R., Noth, Imre, L. Kristin Newby, Lasky, Joseph A., Olman, Mitchell A., Hesslinger, Christian, Leonard, Thomas B., Palmer, Scott M., and Belperio, John A.

Subjects
macromolecular substances, respiratory system, respiratory tract diseases, 3. Good health
Abstract

Additional file 4: Association of MMPs and TIMPs with measures of IPF severity, adjusted for anti-fibrotic treatment.

14. Additional file 2 of Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort

Author

Todd, Jamie L., Vinisko, Richard, Liu, Yi, Neely, Megan L., Overton, Robert, Flaherty, Kevin R., Noth, Imre, L. Kristin Newby, Lasky, Joseph A., Olman, Mitchell A., Hesslinger, Christian, Leonard, Thomas B., Palmer, Scott M., and Belperio, John A.

Subjects
respiratory system, respiratory tract diseases, 3. Good health
Abstract

Additional file 2: MMP and TIMP concentrations (pg/mL) in patients with IPF versus the control population.

Catalog

Books, media, physical & digital resources
See catalog results